Corbion NV

Corbion NV

0QHL · LSE

26.58EUR-0.18 (-0.67%)

Price History

Full chart

Market Stats

Previous Close26.76
Open26.60
Day Range26.58 – 26.74
52-Week Range15.82 – 23.12
Volume21
Market Cap2.15B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.02%
Beta0.94
50-Day Avg28.70
200-Day Avg30.21

About

Corbion N.V. provides lactic acid and derivatives, food preservation solutions, functional ingredient systems, and algae-derived nutritional ingredients in the Netherlands, the United States, Asia, rest of Americas, the rest of Europe, the Middle East, and Africa. It operates in two segments, Functional Ingredients & Solutions, and Health & Nutrition. The company offers antioxidants, fermentation and preservation ingredients, flavors, fortification, functional blends, and lactic acid lactates and derivatives; AlgaPrime DHA, an omega-3 sourcing product; AlgaVia which develops foods and beverages with reduced saturated fat content; CALFEED, a dry lactic acid source to boost feed intake for swine or poultry; LAFEED that helps feed intake and digestive health; LAFEED Powder that acts as a preservative and acidulate; PURAC DW, provides an acidifier, preservative, and antimicrobial in teat-dip applications for animals; PURAC Pet food; PURASOLV; and PURASOLV EL. It also provides PURASORB polymers for medical and pharmaceutical industries; PURASOLV solvents; PURALACT B3 for resin and coating performance; personal care products, such as ESTERLAC Emulsifiers and Surfactants, GLUCONAL ZN, PURAC BF/P41, PURAC HiPure 90, PURAC UltraPure, PURACAL PP/USP, PURAMEX ZN, PURASAL MOISTXS, PURASAL NH/COS, PURASAL S/HQ60, and PURASOLV EL; and GLUCONAL, PURAC PF, PURACAL, PURAMEX, and PURASAL S/PF. In addition, the company offers food solutions, including acidification, color retention, decontamination, food safety and preservation, freshness and shelf life, health and nutrition, strengthening conditioning and texturizing, and taste and texture; PURASORB R&D; biochemical specialties solutions comprising solvency, antimicrobial, moisturization, and pharma; and Algae ingredients solutions. The company was formerly known as CSM N.V. and changed its name to Corbion N.V. in October 2013. Corbion N.V. was founded in 1903 and is headquartered in Amsterdam, the Netherlands.

Company Details

  • CEOMr. Olivier Rigaud
  • Employees2.36K
  • HeadquartersPiet Heinkade 127, Amsterdam, Netherlands, 1019 GM, UK
  • Websitehttps://www.corbion.com

Leadership

  • Mr. Olivier RigaudChairman of the Management Board & CEO · b. 1964
  • Mr. Peter KaziusCFO & Member of Management Board · b. 1972
  • Dr. Yves Boland Ph.D.Chief Technology Officer · b. 1979
  • Mr. Alex SokolowskiHead of Investor Relations
  • Sanne VerhoevenHead of Public Affairs & Communication
  • Ms. Masha Vis-MertensChief Human Resources Officer · b. 1971
  • Mr. Ruud PeerboomsChief Commercial Officer · b. 1969
  • Mr. Oli ArnasonChief Integrated Supply Officer · b. 1976

Financials

Income Statement

Currency: EUR2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-31
Total Revenue911.30M891.70M897.20M976.40M986.50M--
Growth (%)--2.15%+0.62%+8.83%+1.03%--
Cost of Revenue633.90M615.40M639.10M704.10M710.60M--
Gross Profit277.40M276.30M258.10M272.30M275.90M--
Gross Margin30.44%30.99%28.77%27.89%27.97%--
Operating Expense149.40M154.00M170.20M211.00M171.80M--
Operating Income128.00M122.30M87.90M61.30M104.10M--
Operating Margin14.05%13.72%9.80%6.28%10.55%--
Net Income103.60M84.60M54.30M25.80M73.10M--
Net Income Margin11.37%9.49%6.05%2.64%7.41%--
Interest Expense000000-
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%--

Balance Sheet

Currency: EUR2018-12-312019-12-312020-12-312021-12-312022-12-31
Total Assets965.80M1.09B1.07B--
Total Liabilities445.60M562.00M558.50M--
Total Equity520.20M529.10M516.00M--
Total Debt161.00M168.90M284.40M--

Cash Flow

Currency: EUR2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Operating Cash Flow122.60M117.70M99.50M114.40M109.00M22.40M39.00M--
Investing Cash Flow-50.50M-93.50M-87.60M-104.80M-76.90M-119.40M-199.10M--
Financing Cash Flow-102.70M-42.10M-4.30M-12.00M-23.90M85.90M173.90M--
Capital Expenditure55.50M45.50M60.10M76.20M88.90M148.70M235.80M00
Dividends Paid52.50M60.50M32.90M32.90M33.00M33.00M33.00M--

Earnings

Report DateOct 21, 2016Mar 6, 2017Apr 25, 2017Aug 9, 2017Oct 27, 2017Mar 7, 2018Apr 26, 2018Aug 8, 2018Nov 2, 2018Mar 6, 2019Apr 26, 2019Aug 7, 2019Nov 1, 2019Mar 9, 2020Apr 30, 2020Aug 7, 2020Nov 2, 2020Mar 5, 2021Apr 30, 2021Aug 10, 2021Oct 27, 2021Feb 24, 2022Apr 29, 2022Aug 10, 2022Oct 27, 2022Mar 2, 2023Apr 26, 2023Aug 10, 2023Oct 26, 2023Mar 1, 2024Apr 26, 2024Aug 8, 2024Oct 28, 2024Mar 19, 2025Apr 23, 2025Jul 31, 2025Oct 29, 2025Feb 26, 2027
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00-0.00-
EPS Actual0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.390.000.730.00-
Surprise--------------------------------------
Timing-----------------------------Pre-marketAfter-hours----After-hours-Pre-market

Key Statistics & Ratios

Market Cap2.15B
Enterprise Value1.79B
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.00
Price / Book0.00
Book Value13.11
Revenue (TTM)1.25B
Gross Profit (TTM)313.90M
EBITDA169.70M
Profit Margin4.96%
Operating Margin7.27%
Return on Equity8.40%
Return on Assets4.26%
Shares Outstanding0
Shares Float51.51M
Beta0.94
Dividend Yield0.02%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20261×
0.64May 15, 2026
20251×
0.64May 16, 2025
20242×
0.61May 17, 20240.10May 2, 2024
20231×
0.56May 19, 2023
20221×
0.56May 20, 2022
20211×
0.56May 21, 2021
20201×
0.56Jul 1, 2020
20191×
0.56May 15, 2019
20181×
0.56May 29, 2018
20171×
0.44May 17, 2017
20161×
0.43May 16, 2016
20151×
0.21May 26, 2015
20141×
0.15May 14, 2014
20132×
0.70Jul 19, 20130.70May 8, 2013
20121×
0.70May 9, 2012
20111×
0.90May 5, 2011
20101×
0.88May 3, 2010